Feed/Investors/Cormorant Asset Management

Cormorant Asset Management

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on 2 rounds in the feed, most often at Series D+ and in Biotech.

Rounds from 2023-08-23 to 2025-05-22

ROUNDS

joined, none as lead

ROUND SIZES · USD

$113M

across 2 rounds

LATEST ROUND

Series D+ · $38M · 2025-05-22

CO-INVESTORS

named beside it

Rounds

[ 2 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Cormorant Asset Management: 2 rounds · Fireround

Company	Round	Amount	Announced	Role
FORE Biotherapeutics A cancer therapeutics company developing targeted treatments for hard-to-treat tumours	Series D+ Published on thinner evidence, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$38M	2025-05-22	[ PART ]
FORE Biotherapeutics A cancer therapeutics company developing targeted treatments for hard-to-treat tumours	Series D Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$75M	2023-08-23	[ PART ]